Press Releases

DIASORIN AND MEMED PARTNER TO DEVELOP AND COMMERCIALIZE NOVEL HOST IMMUNE RESPONSE BASED DIAGNOSTICS SOLUTION

Licensing Agreement to add MeMed BV™, Immune System Based Protein Signature Test for Distinguishing between Bacterial vs. Viral Infections, to the broad DiaSorin LIAISON test menu, available on LIAISON analyzers

Absolute Antibody Adds SeqPack™ Hybridoma Preservation Kit to Antibody Sequencing Service

Salaso Health’s telemedicine and live exercise platform enable US healthcare teams to stay safely connected with COVID-19 patients

In the current pandemic environment, face-to-face physical therapy visits are less viable due to increasing demands on the healthcare system, as well as the enactment of stay-at-home measures and the reticence of patients particularly those from at-risk groups to visit a clinic or hospital setting.

Matexcel Offers a Wide Selection of Natural Materials for Research Needs

Lifeasible Provides Virus-like Particles Production in Plant

Profacgen Provides Data Analysis Service for Biological Discovery

Phase 2/3 trial suggests that AMZELL’s new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective

The phase 2/3 trial of AMZ001, a novel once daily topical diclofenac formulation, provides efficacy and safety results in the relief of pain associated with knee osteoarthritis (OA)

Maravai LifeSciences Expands TriLink BioTechnologies CleanCap® mRNA Capping Capacity and Adds New Plasmid DNA Manufacturing

Maravai LifeSciences has expanded TriLink BioTechnologies CleanCap® mRNA capping capacity and added new Plasmid DNA manufacturing. It is TriLink’s second manufacturing expansion within a year and will help meet global demand for research, clinical and GMP grade raw materials as well as research and clinical-grade APIs to include mRNA, self-amplifying RNA and plasmid DNA.

Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

• Panthera’s network of UK clinical trials sites grows to seven with several others in development.

BOC Sciences Launched Its PROTACs Technology Platform to Assist Drug Development

The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management.

AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

On August 18, 2020, AI & Medicine, one of the forerunners in the AI-assisted medicine area, announced that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document databases. The firm is a well-known expert in combining artificial intelligence with drug discovery, personalized healthcare and various other medical applications.

Creative Biostructure Released Fluorescence Resonance Energy Transfer (FRET) Assay

Optogenetics Services Now Available at Profacgen

Matexcel Updated Its Bioglass Products Recently

Lifeasible Offers Customized One-stop Service for Seed Testing

Washington COVID-19 biorepository supports global quest for affordable diagnostics

A global resource for the development and validation of COVID-19 diagnostics

VERICHEM LABORATORIES OFFERS LIQUID STABLE, NIST TRACEABLE, COMBINED CHOLESTEROL/URIC ACID STANDARD REFERENCE KIT

The liquid stable, ready-to-use MATRIX PLUS™ Cholesterol Reference Kit, containing known concentrations of both Cholesterol and Uric Acid, is now available from VERICHEM LABORATORIES.

New study published in the Journal of the National Cancer Institute concludes that Epi proColon® is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening

Bioactive Matrixes Products Covering the Full Range Are Now Available at CD Bioparticles

As an established drug delivery company focusing on the development and production of drug delivery systems, CD Bioparticles has released a variety of bioactive matrixes covering reagents&assays, responsive hydrogels, functional biomatrixes and photocrosslinkable kits.